Twelve, a unique kind of chemical company built for the climate period. The invention technology eliminates emissions by turning CO2 into essential products, call it carbon transformation. Reinventing what it means to be a chemical company, on a mission to create a climate-positive world and a fossil-free future.
Carbon transformation company Twelve and biotechnology company LanzaTech has partnered to convert CO2 emissions into polypropylene, a key polymer utilized for medical devices including syringes and IV bags, as well as for large-scale applications in automotive, furniture, textiles, and other everyday products.
“Polypropylene is a key material for essential medical supplies and for many products we rely on in our daily lives. Today, 100 percent of new polypropylene in use worldwide is made from petrochemicals. We now have a way to produce this critical material from CO2 and water instead of from fossil fuels, with no tradeoffs in quality, efficacy or performance. Replacing all of the world’s fossil polypropylene production with CO2 Made polypropylene would reduce carbon emissions by an estimated 700 million tons per year or more,” said Twelve Chief Science Officer, Dr. Etosha Cave.
“By harnessing biology, we can leverage the power of nature to solve a very modern problem. The overabundance of CO2 in our atmosphere has pushed our planet into a state of emergency. We need all carbon transformation solutions to turn this liability into an opportunity, keeping fossil resources in the ground, and our climate safe for everyone,” said LanzaTech CEO, Dr. Jennifer Holmgren.
Twelve’s carbon transformation technology converts CO2 into materials that are traditionally made from fossil fuels. The company helps brands exclude emissions by displacing the petrochemicals in their products and supply chains with CO2Made carbon-negative chemicals and materials, as well as carbon-neutral fuels.
For more details: www.lanzatech.com